Paul R Gillis

Title: Paul R Gillis: Innovator in Angiogenesis Inhibition

Introduction

Paul R Gillis is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medical research, particularly in the area of angiogenesis inhibition. With a total of 7 patents to his name, Gillis has demonstrated a commitment to advancing scientific knowledge and therapeutic methods.

Latest Patents

Gillis's latest patents focus on methods and compositions for inhibiting angiogenesis. One of his key inventions provides a method of inhibiting angiogenesis within a tissue by delivering exogenous PEDF to cells associated with that tissue. The presence of exogenous PEDF plays a crucial role in inhibiting angiogenesis by interfering with the ability of vascular endothelia to expand within the tissue. Additionally, his invention includes a method for determining the severity of a tumor by assaying for the presence of PEDF within the tumor. To facilitate these inventive methods, he has developed pharmaceutical compositions that include sources of PEDF.

Career Highlights

Throughout his career, Paul R Gillis has worked with esteemed institutions such as Northwestern University. His research has contributed to a deeper understanding of angiogenesis and its implications in various medical conditions.

Collaborations

Gillis has collaborated with notable colleagues, including David W Dawson and Susan E Crawford. These partnerships have further enriched his research and innovation efforts.

Conclusion

Paul R Gillis stands out as a significant figure in the field of angiogenesis research. His innovative methods and compositions have the potential to impact medical treatments and improve patient outcomes.